Boston Scientific takes another bite at M&A: the $4.2bn acquisition of BTG

Boston Scientific Corporation (NYSE: BTX) – market cap as of 27/11/2018: USD 48.57bn Introduction On November 20, 2018, Boston Scientific, a company operating as a provider of innovative medical solutions, successfully reached an agreement to acquire BTG plc, the UK developer and distributor of tools employed in the treatment of cancer and other vascular diseases, […]